Featured
-
-
News & Views |
Brain-to-pancreas signalling axis links nicotine and diabetes
The discovery of a signalling axis that connects nicotine responses in the brain with glucose metabolism by the pancreas sheds light on why cigarette smoking increases the risk of diabetes.
- Giuseppe Bruschetta
- & Sabrina Diano
-
Editorial |
After the Integrative Human Microbiome Project, what’s next for the microbiome community?
The latest phase of this ambitious undertaking has provided important insights into inflammatory bowel disease, the onset of type 2 diabetes and preterm birth. But fully integrated multidisciplinary collaborations are now needed to convert knowledge of the microbiome into clinical applications.
-
Perspective
| Open AccessThe Integrative Human Microbiome Project
Over ten years, the Human Microbiome Project has provided resources for studying the microbiome and its relationship to disease; this Perspective summarizes the key achievements and findings of the project and its relationship to the broader field.
- Lita M. Proctor
- , Heather H. Creasy
- & Curtis Huttenhower
-
News & Views |
A map of β-cell differentiation pathways supports cell therapies for diabetes
The use of stem-cell-derived β-cells to replace those destroyed in pancreatic islets has the potential to cure diabetes. A new analysis provides a deep mechanistic understanding of islet-cell differentiation from stem cells.
- Fabian J. Theis
- & Heiko Lickert
-
Outlook |
How artificial intelligence is helping to prevent blindness
Machine learning is being used to automate the detection of eye diseases.
- Sandeep Ravindran
-
Outlook |
Machine diagnosis
The medical benefits of bringing artificial intelligence to eye care outweigh the risks, says Aaron Lee.
- Aaron Lee
-
News |
Human cells reprogrammed to create insulin
Pancreatic cells that don’t normally produce insulin can be modified to do so, and to help control blood sugar levels in diabetic mice.
- Matthew Warren
-
Article |
Diabetes relief in mice by glucose-sensing insulin-secreting human α-cells
Islet non-β-cells from non-diabetic and diabetic human donors are modified via the transcription factors PDX1 and MAFA to produce and secrete insulin in response to glucose.
- Kenichiro Furuyama
- , Simona Chera
- & Pedro L. Herrera
-
Letter |
FOXK1 and FOXK2 regulate aerobic glycolysis
The Forkhead transcription factors FOXK1 and FOXK2, which are induced by starvation, reprogram cellular metabolism to induce aerobic glycolysis.
- Valentina Sukonina
- , Haixia Ma
- & Sven Enerbäck
-
Letter |
Human blood vessel organoids as a model of diabetic vasculopathy
Organoids derived from human stem cells recapitulate the structure and functions of human blood vessels, and can be used to model and identify regulators of diabetic vasculopathy.
- Reiner A. Wimmer
- , Alexandra Leopoldi
- & Josef M. Penninger
-
News & Views |
Location matters for insulin-producing cells
Intrinsic and extrinsic cues drive dynamic processes that control cell fate during organ development. A study of mouse and human cells reveals how these inputs affect cells that make the essential hormone insulin.
- Francesca M. Spagnoli
-
News & Views |
Reduced oxygen consumption by fat cells improves metabolic defects
Low oxygen levels are a hallmark of expanding fat tissue in obesity, and can lead to type 2 diabetes. In addition to a lack of adequate blood supply, increased oxygen demand in fat cells now emerges as being key to this harmful state.
- Nolwenn Joffin
- & Philipp E. Scherer
-
Outlook |
The fight against non-communicable disease in emerging economies
Health-care providers in low- and middle-income countries are shifting their focus away from infections, and towards the bigger problems of diabetes and cardiovascular disease.
- Charles Schmidt
-
Research Highlight |
The serious disease that awaits some ex-smokers
Risk of type 2 diabetes is temporarily higher in those who kick the habit compared with those who keep puffing.
-
News & Views |
Peptide secretion triggers diabetes
An autoimmune attack on cells that make the hormone insulin causes type 1 diabetes. A mouse study reveals that pancreatic-cell release of insulin peptide fragments into the bloodstream triggers this harmful process.
- Jiajie Wei
- & Jonathan W. Yewdell
-
Nature Podcast |
Mexican cavefish, the gut microbiome, and a wearable brain scanner
Shamini Bundell and Benjamin Thompson bring you the latest science news.
-
News & Views |
The healthy diabetic cavefish conundrum
Some Mexican cavefish have a mutation in an insulin receptor protein that affects blood-glucose regulation. The same mutation causes diabetes and health problems in humans, but the diabetic cavefish thrive.
- Sylvie Rétaux
-
News |
Violence and diabetes boom in the Middle East
Rising rates of chronic disease can be curbed only if conflict is brought to an end, say researchers.
- Amy Maxmen
-
Article |
Cryo-EM structure of the activated GLP-1 receptor in complex with a G protein
The structure of the GLP-1 receptor complexed with its ligand offers insight into the mechanism of class B G-protein-coupled receptor activation.
- Yan Zhang
- , Bingfa Sun
- & Georgios Skiniotis
-
News & Views |
Interspecies pancreas transplants
A mouse pancreas grown in a rat controls blood-sugar levels when transplanted into a mouse that models type 1 diabetes. This achievement provides a tantalizing glimpse of how organs could be grown for therapeutic use. See Article p.191
- Qiao Zhou
-
Research Highlights |
Designer cells treat diabetic mice
-
Outlook |
Diabetes: Encapsulating the problem
Cell therapy could cure type 1 diabetes — if only the immune system didn't get in the way.
- Elie Dolgin
-
Letter |
Fatty acid synthesis configures the plasma membrane for inflammation in diabetes
Mice with macrophages deficient in fatty acid synthase exhibit lower levels of diabetes-related insulin resistance and inflammation, qualities that are restored on addition of exogenous cholesterol.
- Xiaochao Wei
- , Haowei Song
- & Clay F. Semenkovich
-
News & Views |
Pancreatic β-cell heterogeneity revisited
Two analyses of insulin-producing β-cells reveal differences in what has long been considered a homogeneous population. These differences might reflect changes during maturation or ageing, or distinct cell lineages. See Letter p.430
- Susan Bonner-Weir
- & Cristina Aguayo-Mazzucato
-
News & Views |
Still a geneticist's nightmare
The largest DNA-sequencing study of type 2 diabetes conducted so far concludes that, contrary to expectation, low-frequency and rare genetic variants do not contribute significantly to disease risk. See Article p.41
- Stephen S. Rich
-
Article |
The genetic architecture of type 2 diabetes
Sequencing data from two large-scale studies show that most of the genetic variation influencing the risk of type 2 diabetes involves common alleles and is found in regions previously identified by genome-wide association studies, clarifying the genetic architecture of this disease.
- Christian Fuchsberger
- , Jason Flannick
- & Mark I. McCarthy
-
Research Highlights |
Growth factor treats diabetes
-
Comment |
Medical research: Time to think differently about diabetes
New guidelines for the surgical treatment of type 2 diabetes bolster hopes of finding a cure, writes Francesco Rubino, but long-standing preconceptions must be put aside.
- Francesco Rubino
-
Research Highlights |
Self-help for type 1 diabetes
-
Research Highlights |
Genes linked to diabetes risk
-
Research Highlights |
Insulin from mini stomach
-
Research Highlights |
Shielded cells treat diabetes
-
Research Highlights |
Personalized diets for health
-
Letter |
Depletion of fat-resident Treg cells prevents age-associated insulin resistance
Fat-resident regulatory T cells (fTreg cells) accumulate in adipose tissue of mice as a function of age, but not obesity; mice without fTreg cells are protected against age-associated insulin resistance, but remain susceptible to obesity-associated insulin resistance and metabolic disease, indicating different aetiologies of age-associated versus obesity-associated insulin resistance.
- Sagar P. Bapat
- , Jae Myoung Suh
- & Ye Zheng
-
Autumn Books |
Nutrition: Dominions of fizz
David Katz applauds an analysis of the carbonated-drinks industry and public health.
- David Katz
-
News & Views |
A smart insulin patch
A microneedle-containing patch that is designed to sense elevated blood glucose levels and to respond by releasing insulin could offer people with diabetes a less-painful and more-reliable way to manage their condition.
- Omid Veiseh
- & Robert Langer
-
Research Highlights |
Gene therapy halts type 1 diabetes
-
Research Highlights |
Stem cells tackle diabetes
-
News |
An inside look at the first pig biobank
Nature watches a porcine autopsy that will help create a powerful animal model of diabetes.
- Alison Abbott
-
Letter |
An ERK/Cdk5 axis controls the diabetogenic actions of PPARγ
Blocking ERK/MAP kinases improves insulin sensitivity thorough a mechanism similar to the actions of the anti-diabetic thiazolidinediones drugs on PPARγ.
- Alexander S. Banks
- , Fiona E. McAllister
- & Bruce M. Spiegelman
-
Article |
Artificial sweeteners induce glucose intolerance by altering the gut microbiota
Non-caloric artificial sweeteners (NAS), widely used food additives considered to be safe and beneficial alternatives to sugars, are shown here to lead to the development of glucose intolerance through compositional and functional changes in the gut microbiota of mice, and the deleterious metabolic effects are transferred to germ-free mice by faecal transplant; NAS-induced dysbiosis and glucose intolerance are also demonstrated in healthy human subjects.
- Jotham Suez
- , Tal Korem
- & Eran Elinav
-
Letter |
Diabetes recovery by age-dependent conversion of pancreatic δ-cells into insulin producers
An investigation of the influence of age on the generation of insulin-producing cells after β-cell loss in mice reveals that, whereas α-cells can reprogram to produce insulin from puberty to adulthood, efficient reconstitution in the very young is through δ-cell reprogramming, leading to complete diabetes recovery.
- Simona Chera
- , Delphine Baronnier
- & Pedro L. Herrera
-
Letter |
High-resolution structure of the human GPR40 receptor bound to allosteric agonist TAK-875
The X-ray crystal structure of human GPR40 receptor in the presence of TAK-875, an orally available, potent and selective human GPR40 agonist.
- Ankita Srivastava
- , Jason Yano
- & Kengo Okada
-
Letter |
Endocrinization of FGF1 produces a neomorphic and potent insulin sensitizer
Pharmacological fibroblast growth factor 1 (FGF1) normalizes blood glucose in diabetic mice by means of an FGF receptor signalling pathway that is independent of its mitogenic activity.
- Jae Myoung Suh
- , Johan W. Jonker
- & Ronald M. Evans
-
Letter |
A common Greenlandic TBC1D4 variant confers muscle insulin resistance and type 2 diabetes
An association mapping study of type-2-diabetes-related quantitative traits in the Greenlandic population identified a common variant in TBC1D4 that increases plasma glucose levels and serum insulin levels after an oral glucose load and type 2 diabetes risk, with effect sizes several times larger than any previous findings of large-scale genome-wide association studies for these traits.
- Ida Moltke
- , Niels Grarup
- & Torben Hansen
-
Letter |
Antidiabetic effects of glucokinase regulatory protein small-molecule disruptors
Two small-molecule disruptors of the glucokinase–glucokinase-regulatory-protein complex, AMG-1694 and AMG-3969, are identified that decrease blood glucose levels in various models of hyperglycaemic rodents.
- David J. Lloyd
- , David J. St Jean Jr
- & Clarence Hale
-
Letter |
Diabetic hyperglycaemia activates CaMKII and arrhythmias by O-linked glycosylation
CaMKII is known to be pathologically activated in heart failure and arrhythmias; here it is shown that glucose-induced CaMKII activation via O-linked glycosylation might contribute to cardiac pathology in diabetes.
- Jeffrey R. Erickson
- , Laetitia Pereira
- & Donald M. Bers
-
Article |
Structure of the human glucagon class B G-protein-coupled receptor
The X-ray crystal structure of the human glucagon receptor, a potential drug target for type 2 diabetes, offers a structural basis for molecular recognition by class B G-protein-coupled receptors.
- Fai Yiu Siu
- , Min He
- & Raymond C. Stevens
-
Letter |
How insulin engages its primary binding site on the insulin receptor
The three-dimensional structure of the insulin–insulin receptor complex has proved elusive, confounded by the complexity of producing the receptor protein; here is the first glimpse of the interaction between insulin and its primary binding site on the insulin receptor, a view based on four crystal structures of insulin bound to truncated insulin receptor complexes.
- John G. Menting
- , Jonathan Whittaker
- & Michael C. Lawrence